Al-Koofee Dhafer A F, Omara Ali M, Abulrazzaq Ali B, Zaid Ruqayah
Department of Clinical Lab. Science, Faculty of Pharmacy, University of Kufa, Najaf, Iraq.
Department of Clinical Biochemistry, Faculty of Medicine, University of Al-Ameed, Karbala, Iraq.
Mater Today Proc. 2022;60:1606-1610. doi: 10.1016/j.matpr.2021.12.132. Epub 2021 Dec 29.
Coronavirus disease -19 (COVID-19) pandemic has extended from late 2019 and continues to this day. The degree of the disease is related to some factors, including age and comorbidities. Obesity is now more widely considered as a main factor of infection, mainly because it has been shown that individuals who are obese have a more severe course of infection with COVID-19. This review study summarized the relationship between the risk of obesity and COVID-19 and detected a difference in reporting from the period of the first pandemic in China to more recent studies. Obesity is a risk factor for developing signs and symptoms of patients with COVID-19 and this review will benefit clinicians by recognizing the role of obesity when giving COVID-19 diagnosis, follow-up, and treatment programs.
冠状病毒病-19（COVID-19）大流行自2019年末开始并持续至今。疾病的严重程度与一些因素有关，包括年龄和合并症。肥胖现在被更广泛地认为是感染的一个主要因素，主要是因为已经表明肥胖个体感染COVID-19后的病程更严重。这项综述研究总结了肥胖风险与COVID-19之间的关系，并发现从中国首次大流行时期到最近的研究在报告方面存在差异。肥胖是COVID-19患者出现体征和症状的一个危险因素，本综述将通过在进行COVID-19诊断、随访和治疗方案时认识到肥胖的作用而使临床医生受益。
